SHINYMOL ZACHARIAH: Open Payments
NPI 1043798515 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $871 · 2025 $565
Food & beverage: $465Education: $100
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $176 |
| Incyte Corporation | 3 | $153 |
| BTG International Inc. | 4 | $82 |
| Karyopharm Therapeutics Inc. | 2 | $63 |
| Lilly USA, LLC | 1 | $34 |
| SOBI, INC | 1 | $29 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $28 |
Products named: DAXXIFY, VORAXAZE, XPOVIO, MONJUVI, JAYPIRCA, Gamifant, ZYNLONTA.
Industry payments across TX — which companies pay providers there.
